Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Veterinary and Comparative Oncology|August 11, 2016
Criteria for designation of clinical substage in canine lymphoma: a survey of veterinary oncologistsL G Barber, K M WeishaarJournal of Veterinary Internal Medicine|November 3, 2010
Efficacy of maropitant in the prevention of delayed vomiting associated with administration of doxorubicin to dogsS E Rau, L G Barber, K E BurgessVeterinary and Comparative Oncology|April 19, 2017
Efficacy of dacarbazine as a rescue agent for histiocytic sarcoma in dogsK A Kezer, L G Barber, S H JenningsJournal of Veterinary Internal Medicine|January 17, 2008
Mushroom-derived maitake PETfraction as single agent for the treatment of lymphoma in dogsP C Griessmayr, M Gauthier, L G Barber, et al.Journal of the American Animal Hospital Association|September 21, 2000
Combined doxorubicin and cyclophosphamide chemotherapy for nonresectable feline fibrosarcomaL G Barber, K U Sørenmo, K L Cronin, et al.Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|September 1, 1996
Neuro-ophthalmologic findings in the Asperger disorderM C Brodsky, L G Barber, B L Lam, et al.Journal of Veterinary Internal Medicine|June 10, 2016
Association between Body Condition Score and Cancer Prognosis in Dogs with Lymphoma and OsteosarcomaF R Romano, C R Heinze, L G Barber, et al.Journal of Veterinary Internal Medicine|August 28, 2009
Dacarbazine as single-agent therapy for relapsed lymphoma in dogsP C Griessmayr, S E Payne, J E Winter, et al.Journal of Veterinary Internal Medicine|February 13, 2009
Antioxidant status and biomarkers of oxidative stress in dogs with lymphomaJ L Winter, L G Barber, L Freeman, et al.Journal of Veterinary Internal Medicine|January 30, 2009
Evaluation of adjuvant doxorubicin-based chemotherapy for the treatment of feline mammary carcinomaC J McNeill, K U Sorenmo, F S Shofer, et al.Pageof 2